The Ministry of Public Security, National Health Commission, and National Medical Products Administration in China have announced the inclusion of bromocaffeine, metonitazene, and etonitazene among a total of 46 substances in the Supplementary Catalogue of Controlled Varieties of Non-Medicinal Anesthetic Drugs and Psychotropic Drugs. This action is in accordance with the Regulations on the Control of Anesthetic and Psychoactive Drugs and Measures for the Administration of Non-Medicinal Anesthetic Drugs and Psychotropic Drugs. The updated regulations will take effect from July 1, 2024.- Flcube.com
Recent news:
-
Sino Biopharmaceutical Submits NDA for Anlotinib and Penpulimab Combo in HCC to NMPA -
Sihuan Pharmaceutical's Huisheng Pharm Strikes Exclusive Deal for Semaglutide Biosimilar in China -
Innovent Biologics' IBI354 Earns Breakthrough Therapy Designation for Ovarian Cancer Treatment -
CDE Includes Double-Crane's Hydroxocobalamine and Sanofi Genzyme's Fitusiran in Rare Disease Care Plan -
Apeiron Therapeutics Initiates Phase Ia/B Study for GTA182 in Solid Tumors with MTAP Deficiency
